EXT1 and breast carcinoma: Here, we endeavored to investigate the role of EXT1 in cancer cell stemness using the doxo-resistant human breast cancer cell line, MCF7/ADR, established by exposing MCF7, a doxo-sensitive human breast cancer cell line, to serially escalated doses of doxo up to 1 μM.